Open AccessEIGHTEEN-MONTH RESULTS OF INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ON VISION AND MICROCIRCULATION IN RADIATION MACULOPATHY
Author(s) -
Chiara M Eandi,
Maria Sole Polito,
Ann Schalenbourg,
Léonidas Zografos
Publication year - 2021
Publication title -
retina
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.24
H-Index - 120
eISSN - 1539-2864
pISSN - 0275-004X
DOI - 10.1097/iae.0000000000003105
Subject(s) - medicine , maculopathy , ophthalmology , ranibizumab , visual acuity , macular edema , retinal , surgery , retinopathy , bevacizumab , diabetes mellitus , chemotherapy , endocrinology
To evaluate 18 months' results of a strict anti-vascular endothelial growth factor protocol for radiation maculopathy following proton therapy in choroidal melanoma.